Autor: |
Ben Abdallah, Ichrak, Ben Nasr, Sonia, Zribi, Aref, Ayarai, Jihene, Fendri, Sana, Mehdi, Balti, Abderrazek, Haddaoui |
Předmět: |
|
Zdroj: |
Clinical Case Reports; Jan2021, Vol. 9 Issue 1, p594-596, 3p |
Abstrakt: |
Although paclitaxel is known to cause mild skin toxicity, it may induce severe HFS requiring drug withdrawal. Patients with high disease burden might receive prolonged paclitaxel chemotherapy. Hence, a grade 2 toxicity would better indicate withdrawal of paclitaxel instead of suspension and rechallenge, to prevent such severe HFS requiring long‐time recovery. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|